Mesoblast (MESO) EBIAT: 2014-2023
Historic EBIAT for Mesoblast (MESO) over the last 8 years, with Jun 2023 value amounting to -$21.6 million.
- Mesoblast's EBIAT fell 2.34% to -$21.6 million in Q2 2023 from the same period last year, while for Jun 2023 it was -$81.9 million, marking a year-over-year increase of 10.35%. This contributed to the annual value of -$102.1 million for FY2025, which is 16.13% down from last year.
- As of Q2 2023, Mesoblast's EBIAT stood at -$21.6 million, which was down 15.42% from -$18.7 million recorded in Q1 2023.
- In the past 5 years, Mesoblast's EBIAT ranged from a high of -$9.3 million in Q3 2019 and a low of -$29.4 million during Q1 2019.
- Over the past 3 years, Mesoblast's median EBIAT value was -$21.5 million (recorded in 2022), while the average stood at -$22.0 million.
- As far as peak fluctuations go, Mesoblast's EBIAT skyrocketed by 55.32% in 2019, and later slumped by 178.18% in 2020.
- Quarterly analysis of 5 years shows Mesoblast's EBIAT stood at -$29.1 million in 2019, then grew by 12.03% to -$25.6 million in 2020, then decreased by 1.90% to -$26.1 million in 2021, then climbed by 5.66% to -$24.6 million in 2022, then dropped by 2.34% to -$21.6 million in 2023.
- Its last three reported values are -$21.6 million in Q2 2023, -$18.7 million for Q1 2023, and -$24.6 million during Q4 2022.